+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Protection against Fasciola gigantica using paramyosin antigen as a candidate for vaccine production



Protection against Fasciola gigantica using paramyosin antigen as a candidate for vaccine production



Pakistan Journal of Biological Sciences 16(22): 1449-1458



Yet no vaccine to protect ruminants against liver fluke infection has been commercialized. In an attempt to develop a suitable vaccine against Fasciola gigantica (F. gigantica) infection in rabbits, using 97 kDa Pmy antigen. It was found that, the mean worm burdens and bile egg count after challenge were reduced significantly by 58.40 and 61.40%, respectively. On the other hand, immunization of rabbits with Pmy induced a significant expression of humoral antibodies (IgM, total IgG, IgG1, IgG2 and IgG4) and different cytokines (IL-6, IL-10, L-12 and TNF-alpha). Among Ig isotypes, IgG2 and IgG4 were most dominant Post-infection (PI) while, recording a low IgG1 level. The dominance of IgG2 and IgG4 suggested late T helper1 (Th1) involvement in rabbit's cellular response. While, the low IgG1 level suggested Th2 response to adult F. gigantica worm Pmy. Among all cytokines, IL-10 was the highest in rabbits immunized with Pmy PI suggesting also the enhancement of Th2 response. It was clear that the native F. gigantica Pmy is considered as a relevant candidate for vaccination against fascioliasis. Also, these data suggested the immunoprophylactic effect of the native F. gigantica Pmy which is mediated by a mixed Th1/Th2 response.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055243496

Download citation: RISBibTeXText

PMID: 24511686


Related references

Protection Against Fasciola gigantica using Paramyosin Antigen as a Candidate for Vaccine Production. 2013

Immunodiagnosis of fascioliasis using sandwich enzyme-linked immunosorbent assay for detection of Fasciola gigantica paramyosin antigen. Tropical Parasitology 3(1): 44-52, 2013

Paramyosin: a candidate vaccine antigen against Schistosoma japonicum. Parasite Immunology 18(1): 49-52, 1996

Detection of circulating antigen in sera of Fasciola gigantica-infected cattle with antibodies reactive with a Fasciola-specific 88-kDa antigen. Veterinary Parasitology 58(3): 235-246, 1995

Host responses during experimental infection with Fasciola gigantica and Fasciola hepatica in Merino sheep II. Development of a predictive index for Fasciola gigantica worm burden. Veterinary Parasitology 154(3-4): 250-261, 2008

Pilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonica. Infection and Immunity 76(7): 3164-3169, 2008

Production and characterization of a monoclonal antibody against 28.5 kDa tegument antigen of Fasciola gigantica. Acta Tropica 84(1): 1-8, 2002

Production and characterization of monoclonal antibodies against excretory-secretary antigen of Fasciola gigantica. Nanjing Nongye Daxue Xuebao. Aug; 243: 81-84, 2001

Cross-protection induced by cross-reactive antigen against Fasciola gigantica and Trichinella spiralis infections. Journal of the Egyptian Society of Parasitology 35(1): 281-294, 2005

Paramyosin as helminth vaccine candidate. Lancet British edition 336(8710): 320, 1990

Development of Paramyosin as a Vaccine Candidate for Schistosomiasis. Frontiers in Immunology 6: 347, 2015

Adaptive immune stimulation is required to obtain high protection with fatty acid binding protein vaccine candidate against Fasciola hepatica in Balb/C mice. Journal of Parasitology 98(3): 527-535, 2012

Monoclonal antibody against recombinant Fasciola gigantica cathepsin L1H could detect juvenile and adult cathepsin Ls of Fasciola gigantica. Parasitology Research 114(1): 133-140, 2015

Vaccine potential of recombinant cathepsin B against Fasciola gigantica. Experimental Parasitology 135(1): 102-109, 2013